CRA HINDS LIQ P/RCA 90ML SBL PRINCIPIO ACTIVO: SIMVASTATINA - EZETIMIBA

Description

PRINCIPIO ACTIVO: SIMVASTATINA - EZETIMIBA 43018

indicado como tratamiento complementario en pacientes con epilepsia parcial o convulsiones tónico-clónicas generalizadas en adultos y adolescentes

Infecciones

SUSTANCIA: NATRAZIM TAB

CRA HINDS LIQ P/RCA 90ML SBL PRINCIPIO ACTIVO: SIMVASTATINA - EZETIMIBA90 ML Botella

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy